Findings reveal new mechanism of activation for ALK St. Jude Children's Research Hospital scientists have shed light on the way ligands bind to and activate ALK, an important target for cancer drug development.. Discovery of how immune cells sense nutrients offers new therapeutic insight St. Jude scientists map nutrient-dependent signaling in T cells, offering possible new drug targets for ....